Are essential medicines available, reliable and affordable in low-middle income countries?
Publication date: Available online 21 December 2018Source: Journal of Cancer PolicyAuthor(s): Tim Eden, Elizabeth Burns, Piera Freccero, Lorna Renner, Vivian Paintsil, Mae Dolendo, Trisha Scanlan, Aye Aye Khaing, Martha Pina, Afiqul Islam, Catherine Chunda-Liyoka, Francine Kouya, Elizabeth MolyneuxAbstractA critical challenge for reducing the cancer survival disparity between children living in low-middle income countries (LMICs) and those in high income countries (HICs) is the apparent lack of consistent supplies of reliable, good quality, effective and affordable essential medicines for curative, supportive and palliativ...
Source: Journal of Cancer Policy - December 22, 2018 Category: Cancer & Oncology Source Type: research
Cancer Control in Member Countries of Organization of Islamic Cooperation (OIC)—A status report & Istanbul Declaration by the First Ladies of OIC
This article summarizes the burden of cancer within the region and presents the İstanbul Declaration by OIC Countries. (Source: Journal of Cancer Policy)
Source: Journal of Cancer Policy - November 9, 2018 Category: Cancer & Oncology Source Type: research
Target Wise and Pound Foolish: A simple technique to evaluate the trade-off between clinical benefit and economic burden of monoclonal antibodies
ConclusionThe “common currency” of NNT provides a concise, clinically relevant approach for framing the debate between individual benefit and public health priorities. Some monoclonal antibodies for some hematology/oncology indications may not meet reasonable thresholds for widespread use. (Source: Journal of Cancer Policy)
Source: Journal of Cancer Policy - November 9, 2018 Category: Cancer & Oncology Source Type: research
Delivery of Cancer Care in Sri Lanka
Publication date: Available online 2 November 2018Source: Journal of Cancer PolicyAuthor(s): Sanjeeva Gunasekera, Sanjeewa Seneviratne, Thiw.a Wijeratne, Christopher M. BoothAbstractSri Lanka, a small island nation in South Asia, is in the process of transition from a low-middle to an upper middle income country. With these changes, the burden of non-communicable disease has increased significantly. Cancer incidence has nearly doubled in twenty-five years. The pattern of cancer is also changing with breast, lung and colorectal cancers showing marked increased incidence compared to traditionally common cancers of the oral c...
Source: Journal of Cancer Policy - November 3, 2018 Category: Cancer & Oncology Source Type: research
The experience of low-income men with prostate cancer transitioning from disease-specific coverage to comprehensive insurance under the affordable care act
ConclusionsTaken together, the results support the integration of disease-specific coverage transition plans, social support, navigation, and educational services into insurance benefits. In the face of resource constraints, disease-specific coverage models may provide critical access to medical services for select populations. (Source: Journal of Cancer Policy)
Source: Journal of Cancer Policy - October 27, 2018 Category: Cancer & Oncology Source Type: research
Cancer prevention policy in the EU: Best practices are now well recognised; no reason for countries to lag behind
Publication date: Available online 9 October 2018Source: Journal of Cancer PolicyAuthor(s): Carolina Espina, Isabelle Soerjomataram, David Forman, Jose M. Martín-MorenoAbstractThrough the application of science to public health practice, National Cancer Control Programmes provide the framework for the development of policies on cancer control, with the ultimate goal of reducing cancer morbidity and mortality, and improving quality of life. In the last decade, a substantial number of Member States in the European Union (EU) have formulated and/or updated their National Cancer Control Programmes, Plans or Strategies includi...
Source: Journal of Cancer Policy - October 10, 2018 Category: Cancer & Oncology Source Type: research
Cost-effectiveness of healthcare interventions for rare cancers: evidence from a systematic literature review and meta-analysis
ConclusionCompared to NICE suggested thresholds and cost-effectiveness ratios of reimbursed interventions for common cancers, interventions for rare cancers seem to be value-for-money. More collaborative research is needed to realise their full potential for improving efficiency and equity in healthcare. (Source: Journal of Cancer Policy)
Source: Journal of Cancer Policy - August 28, 2018 Category: Cancer & Oncology Source Type: research
Teleoncology in sub-Saharan Africa: A literature review
ConclusionsTeleoncology experiences in SSAs suggest the importance of identifying best practices for each local setting. Tailored teleoncology projects should be integrated into whole oncological services to amplify screening, diagnosis, therapies, and palliative care. (Source: Journal of Cancer Policy)
Source: Journal of Cancer Policy - August 18, 2018 Category: Cancer & Oncology Source Type: research
Why is Research in Early-Stage Cancer Research so Low?
Publication date: Available online 2 August 2018Source: Journal of Cancer PolicyAuthor(s): Vinay Prasad, Stephan LindnerAbstractAccording to Budish, Roin and Williams (2015), drug development for early-stage cancer drugs is low because of missing financial incentives, and surrogates can overcome this distortion. We argue that technological barriers can also explain such low drug development. We first summarize medical literature describing these barriers and then augment their data to simultaneously assess the role of incentives versus barriers. Our results suggest that technological barriers suppress research in early-sta...
Source: Journal of Cancer Policy - August 3, 2018 Category: Cancer & Oncology Source Type: research
Time for a European initiative for research to prevent cancer: A manifesto for Cancer Prevention Europe (CPE)
Publication date: Available online 11 July 2018Source: Journal of Cancer PolicyAuthor(s): David Forman, Linda Bauld, Bernardo Bonanni, Hermann Brenner, Karen Brown, Joakim Dillner, Ellen Kampman, Marta Manczuk, Elio Riboli, Karen Steindorf, Hans Storm, Carolina Espina, Christopher P. WildAbstractA landmark resolution on cancer prevention and control was adopted by Member States at the World Health Assembly 2017, noting that “risk reduction has the potential to prevent around half of all cancers” and urging “to promote cancer research to improve the evidence base for cancer prevention and control”. Public health ori...
Source: Journal of Cancer Policy - July 12, 2018 Category: Cancer & Oncology Source Type: research
Trends in antineoplastic receipt after medicare payment reform: Implications for future oncology payment design
ConclusionsOur results indicate that providers responded to reimbursement changes after the MMA by increasing use of newly approved agents, but the magnitude of the response was small and limited to individuals diagnosed with Stage IV disease. (Source: Journal of Cancer Policy)
Source: Journal of Cancer Policy - July 10, 2018 Category: Cancer & Oncology Source Type: research
The health and economic implications of the use of tanning devices
ConclusionsThe use of tanning devices is a significant contributor to illness and premature mortality in the U.S., and also represents a major economic burden in terms of the costs of medical care and lost productivity. (Source: Journal of Cancer Policy)
Source: Journal of Cancer Policy - July 10, 2018 Category: Cancer & Oncology Source Type: research
The Kenya cancer research and control stakeholder program: Evaluating a bilateral partnership to strengthen national cancer efforts
Publication date: Available online 25 March 2017Source: Journal of Cancer PolicyAuthor(s): C. Morgan, M. Cira, A. Karagu, F.C. Asirwa, N.R. Brand, N. Buchanan Lunsford, S.M. Dawsey, A. Galassi, A. Korir, L. Kupfer, P.J. Loehrer, D. Makumi, L. Muchiri, S. Sayed, H. Topazian, J. Welch, M.J. Williams, K. DuncanAbstractBackgroundIn response to a growing cancer burden and need for improved coordination among stakeholders in Kenya, the US National Cancer Institute and the Kenya Ministry of Health collaboratively hosted a stakeholder meeting in 2014 which identified four priority areas of need (research capacity building, patholo...
Source: Journal of Cancer Policy - July 10, 2018 Category: Cancer & Oncology Source Type: research
Making the invisible visible: Oncology nursing efforts of NCI-designated cancer centers in LMICs
Publication date: Available online 27 March 2017Source: Journal of Cancer PolicyAuthor(s): Annette Galassi, Camille Morgan, Catherine MuhaAbstractAn increasing majority of new cancer cases and mortality occur in low- and middle-income countries (LMICs). Nurses provide most cancer care in LMICs, yet receive limited, if any, oncology education and training. To better understand the efforts taking place to address this need, the Center for Global Health (CGH) at the US National Cancer Institute (NCI) undertook a study of global oncology nursing projects at NCI-designated cancer centers. The 62 comprehensive and clinical NCI-d...
Source: Journal of Cancer Policy - July 10, 2018 Category: Cancer & Oncology Source Type: research
Diet and exercise in cancer: Epidemiologic perspectives on optimizing survivorship via lifestyle
Publication date: Available online 6 May 2017Source: Journal of Cancer PolicyAuthor(s): Stacey A. Kenfield, Erin L. Van Blarigan, Meir J. Stampfer, June M. Chan (Source: Journal of Cancer Policy)
Source: Journal of Cancer Policy - July 10, 2018 Category: Cancer & Oncology Source Type: research
